Anna N. A. Tosteson, ScD
Interim Director and Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute
The Dartmouth Institute
Community and Family Medicine
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS
Norris Cotton Cancer Center
The Dartmouth Institute for Health Policy and Clinical Practice
Dartmouth Medical School
One Medical Center Drive
Lebanon NH 03756
Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.
Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )
Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)
PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis
Changes in Mammography Utilization by Women's Characteristics during the First 5 Months of the COVID-19 Pandemic.
Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
The Cost-Effectiveness of Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation for Proximal Humerus Fractures in the Elderly.
Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.
Integration of Registries with EHRs to Accelerate Generation of Real-World Evidence for Clinical Practice and Learning Health Systems Research: Recommendations from a Workshop on Registry Best Practices.
The Development of a Crosswalk for Functional Measures in Postacute Medicare Claims.
Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography.